Faraday Pharmaceuticals Announces Upcoming Investor Engagements

Author: Logan Wright Updated: 09-11-2025 12:17 PM

Upcoming Investor Events by Faraday Pharmaceuticals

Faraday Pharmaceuticals, Inc., a biopharmaceutical company focused on combating heart failure by minimizing myocardial damage in acute ST-elevation myocardial infarction (STEMI), has unveiled its schedule for upcoming investor events. Their mission centers around addressing ischemia-reperfusion injury, a crucial aspect of heart attack recovery.

Oppenheimer's Private Life Sciences Company Showcase

Faraday is excited to partake in Oppenheimer's Private Life Sciences Company Showcase, where they will share insights about their innovative approach to heart health. The event is set for Thursday, September 25, 2025, featuring a presentation by company management at 1:45 PM ET, followed by one-on-one meetings with investors.

Cantor Private Biotech Company Series

On Friday, October 3, 2025, management will participate in the Cantor Private Biotech Company Series. This event will include a fireside chat designed to offer a comprehensive understanding of Faraday's objectives and advancements. Attendees can expect to gain valuable insights at 12:00 PM ET.

5th Annual Needham Private Biotech and MedTech Company Forum

Faraday Pharmaceuticals will also be at the 5th Annual Needham Private Biotech and MedTech Company Forum, scheduled for October 14-15, 2025. This forum emphasizes one-on-one meetings, providing personalized interactions between company representatives and potential investors, fostering deeper relationships and discussions about future endeavors.

How to Engage

Investors interested in one-on-one meetings are encouraged to reach out through their institutional representatives. For those wishing to attend the Cantor fireside chat webinar, contacting a research representative for a registration link is the best way to secure participation.

About Faraday Pharmaceuticals, Inc.

Faraday Pharmaceuticals, Inc. is dedicated to pioneering treatments that prevent heart failure. Established by Dr. Mark Roth, the company aims to mitigate the damage inflicted during severe heart events. With the backing of reputable investors, they continue to thrive in their research and development. For more information about their work and developments, visit www.faradaypharma.com or follow them on social media platforms like LinkedIn.

Contact Information

For inquiries, contact:

Brian Blackman
CFO
bblackman@faradaypharma.com

PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

Frequently Asked Questions

What is the focus of Faraday Pharmaceuticals?

Faraday Pharmaceuticals focuses on developing therapies that prevent heart failure by reducing myocardial damage during acute heart events.

When is the Oppenheimer showcase?

The Oppenheimer showcase is scheduled for September 25, 2025, at 1:45 PM ET.

How can I attend the Cantor fireside chat?

Interested participants should contact their research representatives for a registration link to attend the Cantor fireside chat on October 3, 2025.

What happens at the Needham forum?

The Needham forum offers one-on-one meetings, allowing investors to interact closely with company representatives.

Who founded Faraday Pharmaceuticals?

Dr. Mark Roth of the Fred Hutch Cancer Center is the founder of Faraday Pharmaceuticals.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.